CRDE Sp. J.
Marek Kiersznowski, General Manager
ul. Srebrna 16
Warszawa 00-810 Poland
Phone: +48 22 620 26 62
Fax: +48 22 629 07 95
E-mail:
Web: http://www.crde.com/

 

Company Overview

    CRDE company was founded in 2002 as CRO focused on CEE region. Founders are the people with many years of experience in clinical trials, gathered in the top international pharmaceutical companies and CROs. We have strong practice and know-how of clinical research standards and current technology.

    CRDE provides highly comprehensive services for clinical trials phase I - IV. We offer management of clinical trials from single studies, country specific projects to complex, international ones in a broad range of therapeutic areas through Central and Eastern Europe.

    Our employees are professionals with life sciences degrees, MDs, DVMs, clinical trials know-how, all have undergone our extensive training programs. CRDE is known for its quality, professionalism, flexibility and enthusiasm.

    Studies and their organization are in accordance to the Polish law and ICH-GCP guidelines, EMEA and FDA standards. Maintaining global ICH-GCP standards is possible thanks to constant personnel training. We operate according to our own SOPs or delivered by study sponsor.

    Through collaboration with us you will discover highest quality standards with highest recruitment rates for reasonable costs as well as local expertise.

    We are convinced that cooperation with us will benefit your company

    Marek Kiersznowski, General Manager

 

Clinical Trials in CEE

    • Patients are highly motivated to participate in clinical trials, as they can benefit from new drugs and have access to best physicians and better healthcare
    • Referral network developed
    • High and rapid patient recruitment; 30-80% patients in international trials originate from CEE countries, mostly Poland and Russia
    • Treatment nadve patients (oncology, diabetology, viral hepatitis)
    • GCP standars incorporated into law
    • EU Directive 2001/20/EC incorporated into law of Member States in this region
    • Quality by FDA
      • Number of inspections in CEE countries 1994-2002: 23
      • NAI classification: 13
      • VAI classification: 10
      • OAI classification: 0 Source: FDA FOI web site
    • Reasonable costs and investigators grant

 

COLLABORATION WITH CRDE

    We understand and fulfill your needs.

    Let us improve your clinical research potential

    There are many benefits of collaboration with CRDE :

    • Broad expertise over CEE
    • Experienced and educated staff
    • Access to highly professional sites and regional great patient potential
    • Experience in many therapeutic areas
    • Highest quality, reasonable cost
    • Flexibility and Complexity of service
    • We manage clinical trials phase I-IV from single studies, country specific projects to complex international ones in a broad range of therapeutic areas thorough Central and Eastern Europe.
    • Employees are professionals with life sciences degrees, MDs, DVMs, clinical trials know-how, all have undergone extensive training programs.
    • Studies and their organization are in accordance to Polish law and ICH-GCP guidelines, EMEA and FDA standards.
    • We operate according to our own SOPs or delivered by study sponsor.

    Indication

    Phase

    Cardiology (hypertension)

    III

    Cardiology (hypertension)

    II

    Dermatology

    IV

    Diabetology (DM t2)

    III

    Diabetology (DM t2)

    III

    Nephrology

    III

    Nephrology

    I

    Surgery

    III

    Gynecology

    IV

    Gynecology

    III

    Rhematology (RA)

    II

    Rheumatology (RA)

    III

    Rheumatology (Coxarthrosis)

    III

    Oncology (Breast tumor)

    II

    Oncology (colorectal cancer)

    III

    Oncology (prostate tumor)

    III

    Opthalmology

    III

    Gastroenterology

    III

    Pulmonology (COPD)

    III

 

CRDE CLINICAL RESEARCH SERVICES

    • CLINICAL TRIAL PROJECT MANAGEMENT
    • CLINICAL TRIAL MONITORING
    • PHASE I, BIOAVAILABILITY, BIOEQUIVALENCE STUDIES
    • DATA MANAGEMENT, EDC, BIOSTATISTICS
    • MEDICAL WRITING (PROTOCOL, CRF, REPORTS)
    • FEASIBILITY STUDIES
    • QUALITY ASSURANCE
    • REGULATORY HANDLING
    • PMS STUDIES
    • RESCUE STUDIES
    • MEDICAL DEVICES
    • EDUCATIONAL SERVICES

    CLINICAL TRIALS MANAGEMENT
    OUR SERVICES INCLUDE:

    • Protocol generation and CRF design
    • CRFs production
    • eCRFs design and production
    • Informed consent design and translations
    • Sites feasibility, assessment and selection
    • Regulatory and Ethics approvals
    • Trainings for site personnel
    • Investigator meetings
    • Investigational product shipment and inventory
    • Sites initiation
    • Ongoing, routine monitoring
    • Investigator grant administration
    • Drug supplies handling
    • Compliance management
    • Patient recruitment support
    • Managing CRAs network
    • Project management
    • EDC trials monitoring
    • EDC trainings, consultancy and helpdesk

    PHASE I UNIT

    TYPE OF STUDIES:

    • First administration
    • Bioequivalence
    • Bioavailability
    • Drug - Food interaction
    • Drug - Drug interaction
    • Pharmacokinetics/pharmacodynamics
    • Drug metabolism
    • Safety and tolerability
    • Dose finding

    DATA MANAGEMENT
    DATA MANAGEMENT SERVICES INCLUDE:

    • CONSULTANCY
    • CONVENTIONAL AND ELECTRONIC DATA MANAGEMENT INCULUDING CRF DESIGN AND MEDICAL CODING
    • EDC SUPPORT
    • FUNCTIONAL SUPPORT
    • ORACLE CLINICAL & ORACLE THESAURUS MANAGEMENT SYSTEM
    • TRAINING

    MEDICAL WRITING

    • PROTOCOL
    • CASE REPORT FORM
      • e-CRF PREPARATION
    • FINAL REPORT
    • PATIENT DIARY

    FEASIBILITY STUDIES

    • CRDE helps to identify experienced investigators and right patient populations. We provide to our sponsor important data about:
      • recruitment challenges,
      • timelines,
      • budget.
    • We provide feasibility studies through whole Europe

    QUALITY ASSURANCE
    CRDE quality assurance staff provides:

    • In house System Audits for monitoring procedures
    • On site audits, routine and for cause
    • Compliance Management
    • Site preparation to inspections
    • Trainings for company and site staff on FDA inspection
    • Training for CRAs
    • Independent translators during FDA and EMEA inspection
    • Consultancy on SOPs writing

    PMS STUDIES
    CRDE provides you with full service in PMS studies from study planning and design to final report:

    • Planning and setup of study plan, simplified protocol and abbreviated CRF
    • Sites selection
    • Project management
    • Data entry and validation
    • Statistical analysis and reporting

    The benefits for your company of PMS study conducted by CRDE are as follows:

    • More data about safety profile of your product
    • Increased awareness of your company product in medical practice
    • Publications of study results in widely recognised journals

    RESCUE STUDIES
    CRDE takes over clinical trials all phases, that didn’t meet planned timelines due to:

    • poor recruiment
    • incorrect project management and monitoring
    • bancrupcy of CRO
    • other reasons

    MEDICAL DEVICES
    CRDE performs clinical trials of MEDICAL DEVICES:

    • Trials are conducted according to:
      • local legal requirements
      • GCP standards
      • FDA guidelines
      • ISO requirements
    • We help to obtain certification of CE sign

    TRAININGS
    Our trainings:

    • Introduction to clinical trials monitoring for beginners
    • Intermediate clinical trials monitoring
    • Project management in clinical research
    • GCP for investigators
    • Bioequivalence and bioavailability studies
    • Clinical trial audits and inspections
    • Negotiation skills for CRAs
    • Presentation skills
    • Clinical trial design
    • Polish, European and USA regulatory requirements in clinical research and other

 

OUR CLIENTS

    • Adamed
    • Amgen
    • Aventis
    • Bayer
    • Beaufour Ipsen
    • BIOMED Lublin
    • Boehringer Ingelheim
    • Bonne Sante
    • CRC Development
    • CROM
    • CRO Poland
    • ELI LILLY Polska
    • Fresenius Kabi Polska
    • Imform Polska
    • Janssen-Cilag Polska
    • Clinical Research Consulting
    • KENDLE Branches
    • Lundbeck Poland
    • MDS Pharma Services Poland
    • MSD Polska
    • NMCT Poland
    • Novartis Poland
    • Novo Nordisk
    • Organon Polska
    • Pfizer Polska
    • PHARMANET
    • Pierre Fabre
    • Pol-Nil
    • Polfa Tarchomin
    • Polfa Warszawa
    • PRA
    • Quantum Satis
    • Sanofi Synthelabo
    • Schering AG
    • Scope International Poland
    • STATMED
    • Wyeth

 

CONTACT

    Marek Kiersznowski
    General Manager
    Marek.Kiersznowski@crde.com

    Roman Puchala
    Business Development Manager
    Roman.Puchala@crde.com

 

Contact Information

    CRDE Sp. J.
    Marek Kiersznowski, General Manager
    ul. Srebrna 16
    Warszawa 00-810 Poland
    Phone: +48 22 620 26 62
    Fax: +48 22 629 07 95
    E-mail:

    If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:

Address:

City:

State:

Zip:

Phone:

Email address:

Message:

 

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.


Back to Profiles of Industry Providers


Click here to access this Center's WWW home page.

Last updated on February 19, 2008

PAC>(counter)

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA